{"id":"antidepressant-non-response","_chembl":{"chemblId":"CHEMBL450072","moleculeType":"Small molecule","molecularWeight":"140.23"},"_dailymed":null,"_scrapedAt":"2026-03-28T04:34:35.263Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779122971,"model":"claude-sonnet-4-5-20250929"},"description":"Antidepressant non-response refers to the clinical scenario where patients with depression do not achieve adequate symptom improvement despite appropriate antidepressant treatment. This is a therapeutic challenge rather than a specific drug, representing an unmet medical need in psychiatry.","indications":{"approved":[{"status":"investigational","condition":"Treatment-resistant depression","patientPopulation":"Adults with inadequate response to antidepressants"}]},"trialDetails":[{"nctId":"NCT06559306","phase":"PHASE3","title":"Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms","status":"RECRUITING","sponsor":"Janssen Research & Development, LLC","startDate":"2024-07-25","conditions":"Depressive Disorder, Major","enrollment":752},{"nctId":"NCT07266545","phase":"PHASE4","title":"RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-02-17","conditions":"Unipolar Depression, Bipolar Depression","enrollment":120},{"nctId":"NCT06805851","phase":"","title":"Impact of Depression on Thermoregulation","status":"RECRUITING","sponsor":"Penn State University","startDate":"2025-03-01","conditions":"Depression, Selective Serotonin Reuptake Inhibitor","enrollment":64},{"nctId":"NCT05814640","phase":"PHASE1, PHASE2","title":"Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)","status":"RECRUITING","sponsor":"First Affiliated Hospital of Chongqing Medical University","startDate":"2023-02-20","conditions":"Depression, Sequestra","enrollment":520},{"nctId":"NCT04747314","phase":"PHASE2, PHASE3","title":"Treating Negative Affect in Low Back Pain Patients","status":"COMPLETED","sponsor":"Ajay Wasan, MD, Msc","startDate":"2021-03-31","conditions":"Chronic Low Back Pain, Negative Affectivity","enrollment":308},{"nctId":"NCT06450704","phase":"NA","title":"Cerebral and Anti-inflammatory Response Through Exercise - Mechanisms In Depressive Disorders","status":"RECRUITING","sponsor":"Fundación de Investigación Biomédica - Hospital Universitario de La Princesa","startDate":"2025-04-21","conditions":"Major Depressive Disorder, Inflammatory Response","enrollment":124},{"nctId":"NCT00308893","phase":"PHASE4","title":"BDNF Gene Polymorphism and Antidepressants Treatment","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2006-07","conditions":"Depression","enrollment":188},{"nctId":"NCT06433635","phase":"PHASE4","title":"Sequential Multiple Assignment Randomized Trial for Bipolar Depression","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2024-10-01","conditions":"Bipolar I Disorder, Depression","enrollment":2726},{"nctId":"NCT06511908","phase":"PHASE2","title":"Investigation of the Antidepressant Effects of (2R,6R)-HNK, an Enhancer of Synaptic Glutamate Release, in Treatment-Resistant Depression","status":"RECRUITING","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2024-11-06","conditions":"Suicide, Depressive Disorder, Treatment-Resistant, Ketamine","enrollment":50},{"nctId":"NCT06034821","phase":"PHASE4","title":"Comparative Effectiveness of ECT vs. KETAMINE Over the Lifespan","status":"ENROLLING_BY_INVITATION","sponsor":"Brigham and Women's Hospital","startDate":"2023-10-01","conditions":"Acute Suicidal Depression (ASD)","enrollment":1500},{"nctId":"NCT03466346","phase":"NA","title":"SMART-DAPPER: Leveraging the Depression And Primary-care Partnership for Effectiveness-implementation Research Project","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2020-08-31","conditions":"Depression, Unipolar, Posttraumatic Stress Disorder, Trauma","enrollment":2162},{"nctId":"NCT06384209","phase":"NA","title":"The Friendship Bench Plus Trial","status":"RECRUITING","sponsor":"University of Bern","startDate":"2025-06-26","conditions":"Major Depressive Disorder, Severe Depressive Episode Without Psychotic Symptoms","enrollment":296},{"nctId":"NCT07105397","phase":"NA","title":"Evaluating Conversational Artificial Intelligence for Depression Management","status":"NOT_YET_RECRUITING","sponsor":"George Mason University","startDate":"2026-04-15","conditions":"Major Depressive Disorder (MDD)","enrollment":130},{"nctId":"NCT06894680","phase":"NA","title":"Integrating Depression Care Into HIV Services for Older People With HIV Using a Stepped Care, Task-Sharing Approach.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Royal Society of Tropical Medicine and Hygiene","startDate":"2025-03-24","conditions":"Older Adults (50-90 Years), Depression","enrollment":120},{"nctId":"NCT04142177","phase":"NA","title":"Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2022-06-13","conditions":"Chronic Low Back Pain","enrollment":2529},{"nctId":"NCT04973930","phase":"PHASE3","title":"Feasibility Trial of Tele-IPT and Tele-Pharmacotherapy for Patients With Depression and Non-Metastatic Breast Cancer","status":"SUSPENDED","sponsor":"New York State Psychiatric Institute","startDate":"2022-03-01","conditions":"Major Depressive Disorder, Breast Cancer, Venlafaxine","enrollment":20},{"nctId":"NCT02417064","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-10","conditions":"Treatment-resistant Depression","enrollment":346},{"nctId":"NCT02493868","phase":"PHASE3","title":"A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-10-01","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":719},{"nctId":"NCT02418585","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-07","conditions":"Treatment-resistant Depression","enrollment":236},{"nctId":"NCT02497287","phase":"PHASE3","title":"A Long-term, Safety and Efficacy Study of Intranasal Esketamine in Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-09-30","conditions":"Treatment-resistant Depression","enrollment":802},{"nctId":"NCT02422186","phase":"PHASE3","title":"A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2015-08-20","conditions":"Depressive Disorder, Treatment-Resistant","enrollment":139},{"nctId":"NCT05109195","phase":"","title":"A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor Antidepressant","status":"TERMINATED","sponsor":"Janssen Research & Development, LLC","startDate":"2021-10-26","conditions":"Depressive Disorder, Major","enrollment":7},{"nctId":"NCT04521478","phase":"PHASE2","title":"A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression","status":"COMPLETED","sponsor":"Boehringer Ingelheim","startDate":"2020-11-20","conditions":"Depressive Disorder, Major","enrollment":389},{"nctId":"NCT04101474","phase":"NA","title":"Role Of Ketamine in Treatment-Resistant Major Depressive Disorder And Its Effect on Suicidality","status":"COMPLETED","sponsor":"Assiut University","startDate":"2020-09-01","conditions":"Treatment Resistant Depression","enrollment":36},{"nctId":"NCT05616559","phase":"","title":"Precision Medicine in the Depression Treatment","status":"RECRUITING","sponsor":"Rigshospitalet, Denmark","startDate":"2021-06-15","conditions":"Depressive Disorder, Major, Treatment Outcome, Cognitive Dysfunction","enrollment":800},{"nctId":"NCT04120480","phase":"NA","title":"Effectiveness of PGx Testing","status":"ACTIVE_NOT_RECRUITING","sponsor":"Kaiser Permanente","startDate":"2019-11-15","conditions":"Polypharmacy","enrollment":600},{"nctId":"NCT05866575","phase":"NA","title":"Prediction of the Therapeutic Response in Depression Based on Neuro-computational Modeling Assessment of Motivation","status":"RECRUITING","sponsor":"Centre Hospitalier St Anne","startDate":"2023-09-12","conditions":"Major Depressive Disorder","enrollment":136},{"nctId":"NCT04777006","phase":"PHASE4","title":"Integrating a Stepped Care Model of Screening and Treatment for Depression Into Malawi's National HIV Care Delivery Platform","status":"ACTIVE_NOT_RECRUITING","sponsor":"RAND","startDate":"2021-09-01","conditions":"Depressive Disorder","enrollment":487},{"nctId":"NCT06337539","phase":"","title":"Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants","status":"NOT_YET_RECRUITING","sponsor":"Germans Trias i Pujol Hospital","startDate":"2024-04-01","conditions":"Depression, Inflammation, Antidepressants","enrollment":50},{"nctId":"NCT06131268","phase":"PHASE4","title":"The Role of Negr1 In Modulating Neuroplasticity in Major Depression (RONIN)","status":"UNKNOWN","sponsor":"Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico","startDate":"2022-03-01","conditions":"Major Depressive Disorder, Bipolar Affective Disorder, Currently Depressed, Moderate","enrollment":30},{"nctId":"NCT05390736","phase":"NA","title":"Evaluating the Cost Effectiveness of STEADI","status":"COMPLETED","sponsor":"National Opinion Research Center","startDate":"2020-07-29","conditions":"Accidental Fall","enrollment":780},{"nctId":"NCT03538691","phase":"PHASE3","title":"A Trial to Evaluate the Efficacy, Safety & Tolerability of Brexpiprazole in the Maintenance Treatment of Adults With Major Depressive Disorder","status":"COMPLETED","sponsor":"Otsuka Pharmaceutical Development & Commercialization, Inc.","startDate":"2018-07-13","conditions":"Major Depressive Disorder","enrollment":1149},{"nctId":"NCT05959187","phase":"NA","title":"A Single-center Randomized Controlled Study on the Effect of Pharmacogenomics Trial on Clinical Efficacy in Patients With Depression","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2020-07-15","conditions":"Depressive Disorder, Pharmacogenomic Drug Interaction","enrollment":665},{"nctId":"NCT02058693","phase":"PHASE4","title":"Adjunctive Mixed Salts Amphetamine for Depressed Adults With Incomplete Response to Current Antidepressant Therapy","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2010-12","conditions":"Major Depressive Disorder","enrollment":41},{"nctId":"NCT03555669","phase":"NA","title":"Project SOAR-Mental Health Malawi: Depression and HIV Integration","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2017-04-24","conditions":"Depression, HIV/AIDS","enrollment":2082},{"nctId":"NCT03761030","phase":"PHASE4","title":"L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2019-01-09","conditions":"Major Depressive Disorder, Dysthymia, Depression","enrollment":51},{"nctId":"NCT03872492","phase":"NA","title":"Major Depressive Disorder: Early Prediction of Non-response to Antidepressant Therapy Via a Mobile Digital Scale","status":"TERMINATED","sponsor":"Ad scientiam","startDate":"2019-10-17","conditions":"Depressive Disorder, Major","enrollment":92},{"nctId":"NCT04342299","phase":"","title":"The Antidepressant Advisor (Study 3): fMRI Study to Predict Treatment Response in Patients With Depression","status":"COMPLETED","sponsor":"King's College London","startDate":"2018-08-01","conditions":"Major Depressive Disorder","enrollment":45},{"nctId":"NCT04076644","phase":"NA","title":"Maintenance Transcranial Magnetic Stimulation in Major Depressive Disorder","status":"COMPLETED","sponsor":"University of Missouri-Columbia","startDate":"2019-09-01","conditions":"MDD","enrollment":11},{"nctId":"NCT05568823","phase":"NA","title":"Biomarkers of ANTidepressant RESponse and Development Risk of Bipolar Disorder","status":"UNKNOWN","sponsor":"Assistance Publique Hopitaux De Marseille","startDate":"2022-11-01","conditions":"Depression, Bipolar, Major Depressive Disorder, Bipolar Disorder","enrollment":244},{"nctId":"NCT04697693","phase":"PHASE4","title":"Antidepressant Response in Older Adults With Comorbid PTSD and MDD","status":"TERMINATED","sponsor":"New York State Psychiatric Institute","startDate":"2021-03-03","conditions":"Post Traumatic Stress Disorder, Major Depressive Disorder","enrollment":1},{"nctId":"NCT01973283","phase":"PHASE4","title":"Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2014-02-19","conditions":"Major Depressive Disorder, Dysthymic Disorder, Depressive Disorder, NOS","enrollment":100},{"nctId":"NCT01931202","phase":"NA","title":"Mechanisms of Antidepressant Non-Response in Late-Life Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2014-02-19","conditions":"Major Depressive Disorder","enrollment":138},{"nctId":"NCT01272531","phase":"","title":"Pharmacogenomics of Mood Stabilizer Response in Bipolar Disorder (PGBD)","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2011-04","conditions":"Bipolar Affective Disorder","enrollment":560},{"nctId":"NCT02466477","phase":"PHASE4","title":"Pharmacogenomic Decision Support With GeneSight Psychotropic to Guide the Treatment of Major Depressive Disorder","status":"COMPLETED","sponsor":"Assurex Health Inc.","startDate":"2015-06","conditions":"Depressive Disorder, Major, Depression, Depressive Disorder","enrollment":542},{"nctId":"NCT02109939","phase":"NA","title":"Genomics Used to Improve DEpression Decisions","status":"COMPLETED","sponsor":"Assurex Health Inc.","startDate":"2014-04","conditions":"Major Depressive Disorder (MDD)","enrollment":1398},{"nctId":"NCT02805439","phase":"PHASE2","title":"Efficacy and Safety of S 47445 Versus Placebo as Adjunctive Treatment in Depressed Patients Not Fully Recovered From Depressive Symptoms With a Current Antidepressant Treatment","status":"COMPLETED","sponsor":"Institut de Recherches Internationales Servier","startDate":"2016-03","conditions":"Major Depressive Disorder","enrollment":400},{"nctId":"NCT04171193","phase":"PHASE2","title":"Efficacy of Deep Anaesthesia With Isoflurane as a Fast-response Antidepressant Agent","status":"UNKNOWN","sponsor":"University of Sao Paulo","startDate":"2019-12","conditions":"Depressive Disorder, Major, Treatment Resistant Depression, Depressive Episode","enrollment":30},{"nctId":"NCT02869035","phase":"PHASE1","title":"Treatment Outcome in Major Depressive Disorder","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2016-08","conditions":"Major Depressive Disorder","enrollment":100},{"nctId":"NCT03934723","phase":"NA","title":"Does Antidepressant Use Blunt Adaptations to Exercise?","status":"UNKNOWN","sponsor":"California State University, San Marcos","startDate":"2019-06-15","conditions":"Depression, Depressive Disorder, Metabolic Syndrome","enrollment":24},{"nctId":"NCT02358343","phase":"PHASE3","title":"A Trial of Sertraline vs. CBT for End-stage Renal Disease Patients With Depression {ASCEND}","status":"COMPLETED","sponsor":"University of Washington","startDate":"2015-03-23","conditions":"Depression, End Stage Renal Disease","enrollment":184},{"nctId":"NCT02181231","phase":"PHASE1, PHASE2","title":"Buprenorphine Used With Treatment Resistant Depression in Older Adults","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2016-06-01","conditions":"Major Depressive Disorder, Depression","enrollment":18},{"nctId":"NCT03432221","phase":"","title":"Switching From SSRI to Desvenlafaxine on Cognitive Functioning","status":"UNKNOWN","sponsor":"Corporacion Parc Tauli","startDate":"2018-04-03","conditions":"Major Depressive Disorder","enrollment":36},{"nctId":"NCT03547219","phase":"NA","title":"Biomarkers of Antidepressant Response and Suicidal Events in Depressed Youth","status":"COMPLETED","sponsor":"Seoul National University","startDate":"2015-08-05","conditions":"Depression, Adolescent","enrollment":152},{"nctId":"NCT00456014","phase":"NA","title":"Pre-Treatment Positron Emission Topography Scanning for Increasing Success in Antidepressant Treatment","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-09","conditions":"Depression","enrollment":37},{"nctId":"NCT00787501","phase":"PHASE1","title":"Imaging Antidepressant vs. Cognitive Behavior Therapy Effects on Unipolar Depression","status":"COMPLETED","sponsor":"University of Pittsburgh","startDate":"2008-06","conditions":"Major Depressive Disorder","enrollment":98},{"nctId":"NCT02583230","phase":"NA","title":"Mobile Technology to Engage and Link Patients and Providers in Antidepressant Treatment (MedLink)","status":"COMPLETED","sponsor":"Northwestern University","startDate":"2014-04","conditions":"Depression","enrollment":11},{"nctId":"NCT02752178","phase":"","title":"Peripheral Immunomarker Validation in Treatment-resistant Depression","status":"COMPLETED","sponsor":"University of Cambridge","startDate":"2015-06","conditions":"Depressive Disorder, Major","enrollment":393},{"nctId":"NCT03606850","phase":"NA","title":"Transcranial Magnetic Stimulation Study of Cortical Excitability as Marker of Antidepressant Response: EXCIPSY Study","status":"UNKNOWN","sponsor":"Centre Hospitalier du Rouvray","startDate":"2018-07-30","conditions":"Major Depressive Disorder","enrollment":22},{"nctId":"NCT02263248","phase":"PHASE1, PHASE2","title":"Incomplete Response in Late-Life Depression: Getting to Remission With Buprenorphine","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2014-12","conditions":"Major Depressive Disorder, Depression","enrollment":56},{"nctId":"NCT02441387","phase":"","title":"Predictors of the Outcome of Late Life Depression","status":"UNKNOWN","sponsor":"University of Sao Paulo General Hospital","startDate":"2015-04","conditions":"Major Depression","enrollment":120},{"nctId":"NCT01943435","phase":"NA","title":"Study Comparing 3 Different Treatments for Arthritis of the Lower Back (Lumbar Spinal Stenosis)","status":"COMPLETED","sponsor":"Michael Schneider, DC, PhD","startDate":"2013-11-20","conditions":"Lumbar Spinal Stenosis","enrollment":259},{"nctId":"NCT02330068","phase":"","title":"Microbiome of Depression & Treatment Response to Citalopram","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2014-12","conditions":"Major Depressive Disorder, Bipolar I and Bipolar II","enrollment":34},{"nctId":"NCT02332954","phase":"PHASE4","title":"Assessment in Work Productivity and the Relationship With Cognitive Symptoms in Patients With MDD Taking Vortioxetine","status":"COMPLETED","sponsor":"Lundbeck Canada Inc.","startDate":"2015-02","conditions":"Major Depressive Disorder","enrollment":226},{"nctId":"NCT02178696","phase":"PHASE4","title":"Predictors of Antidepressant Response","status":"COMPLETED","sponsor":"University of Michigan","startDate":"2011-01","conditions":"Depression","enrollment":44},{"nctId":"NCT01658228","phase":"PHASE4","title":"Combination Treatment Study for Memory Impairment and Depression","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2011-09","conditions":"Depression, Mild Cognitive Impairment","enrollment":86},{"nctId":"NCT00519428","phase":"PHASE4","title":"Does Dual Therapy Hasten Antidepressant Response?","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2007-08","conditions":"Major Depressive Disorder","enrollment":245},{"nctId":"NCT01557946","phase":"PHASE4","title":"Glutamatergic and GABAergic Mediators of Antidepressant Response in Major Depression","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2012-03","conditions":"MDD, Citalopram, Major Depressive Disorder","enrollment":32},{"nctId":"NCT02857036","phase":"NA","title":"Rhythm and Depression","status":"UNKNOWN","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2013-07","conditions":"Depression","enrollment":80},{"nctId":"NCT02014363","phase":"PHASE2","title":"Safety and Efficacy Study Comparing ETS6103 With Amitriptyline in the Treatment of Major Depressive Disorder (MDD)","status":"COMPLETED","sponsor":"e-Therapeutics PLC","startDate":"2013-10","conditions":"Major Depressive Disorder","enrollment":164},{"nctId":"NCT02546024","phase":"","title":"Predictors of Treatment Response in Late-onset Major Depressive Disorder","status":"SUSPENDED","sponsor":"King's College London","startDate":"2015-09","conditions":"Depressive Disorder, Major","enrollment":40},{"nctId":"NCT02800577","phase":"PHASE1","title":"Using Computer Tasks to Predict Response to Antidepressants","status":"COMPLETED","sponsor":"P1vital Products Limited","startDate":"2014-06","conditions":"Depression","enrollment":80},{"nctId":"NCT01099592","phase":"PHASE4","title":"Antidepressants to Promote Recovery of Cardiac Patients Suffering From Depression","status":"TERMINATED","sponsor":"Centre hospitalier de l'Université de Montréal (CHUM)","startDate":"2010-11","conditions":"Acute Coronary Syndrome, Major Depressive Episode","enrollment":7},{"nctId":"NCT01352572","phase":"NA","title":"Effects of Antidepressant on Postsynaptic Signal Transduction in Serotonergic System of Depressed Patients","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2002-01","conditions":"Depression","enrollment":300},{"nctId":"NCT00817375","phase":"NA","title":"Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2003-02","conditions":"Depression, Adverse Reaction to Drug","enrollment":1000},{"nctId":"NCT00817011","phase":"NA","title":"Development of Pharmacogenomic Method to Predict Antidepressant Responsiveness","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2006-04","conditions":"Depression, Antidepressant Drug Adverse Reaction","enrollment":1000},{"nctId":"NCT01352559","phase":"NA","title":"Prediction of Antidepressant Response Using Pharmacogenetics and Peripheral Lymphocytic Phenotype","status":"UNKNOWN","sponsor":"Samsung Medical Center","startDate":"2001-11","conditions":"Depression","enrollment":1000},{"nctId":"NCT01479920","phase":"NA","title":"A Positron Emission Topographic (PET) Study on Depression Patient With Electroacupuncture","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2012-06","conditions":"Major Depressive Disorder, Depression","enrollment":36},{"nctId":"NCT01670019","phase":"PHASE4","title":"Antidepressant Plus Asenapine Versus Antidepressant Plus Placebo for Depression","status":"COMPLETED","sponsor":"Duke University","startDate":"2012-10","conditions":"Major Depressive Disorder Without Psychotic Features","enrollment":46},{"nctId":"NCT01051466","phase":"PHASE4","title":"A Study of the Neurobiology of Depression","status":"COMPLETED","sponsor":"Eli Lilly and Company","startDate":"2010-01","conditions":"Major Depressive Disorder, Healthy Participants","enrollment":60},{"nctId":"NCT01597661","phase":"","title":"Bupropion & Cardio Birth Defect (Slone)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-09","conditions":"Depressive Disorder","enrollment":1},{"nctId":"NCT01184235","phase":"","title":"Multidimensional Measurement of Psychopharmacological Treatment Response","status":"COMPLETED","sponsor":"Child Psychopharmacology Institute","startDate":"2010-08","conditions":"Autism Spectrum Disorders, Mood Disorders, Sleep Disorders","enrollment":44},{"nctId":"NCT01174394","phase":"NA","title":"Electroacupuncture Combined With Antidepressants for Post-stroke Depression","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2010-05","conditions":"Depression, Stroke","enrollment":43},{"nctId":"NCT00375843","phase":"PHASE4","title":"Brain Activity Changes and Treatment Response in Depressed People Who Are Receiving Antidepressant Medication","status":"COMPLETED","sponsor":"National Institute of Mental Health (NIMH)","startDate":"2005-01","conditions":"Depression","enrollment":118},{"nctId":"NCT01492621","phase":"PHASE4","title":"Effect of Antidepressants on White Matter Structure","status":"UNKNOWN","sponsor":"Centre de Recherche de l'Institut Universitaire en santé Mentale de Montréal","startDate":"2011-11","conditions":"Major Depression","enrollment":40},{"nctId":"NCT00437385","phase":"PHASE1","title":"Evaluation of Three Continuation Therapies After ECT Concerning Efficacy and Cognition in Severly Depressed Patients","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2005-03","conditions":"Depression, Major Depression","enrollment":90},{"nctId":"NCT00995696","phase":"PHASE2","title":"Treatment Follow-up Study","status":"COMPLETED","sponsor":"Nationwide Children's Hospital","startDate":"2008-09","conditions":"Interactive Voice Response (IVR)","enrollment":800},{"nctId":"NCT01292499","phase":"NA","title":"Italian Network for the Improvement of Compliance in Depression","status":"UNKNOWN","sponsor":"Ospedale Amedeo di Savoia","startDate":"2009-03","conditions":"Depression","enrollment":1264},{"nctId":"NCT01282632","phase":"PHASE1, PHASE2","title":"Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression","status":"COMPLETED","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2002-08","conditions":"Subjects Had Unipolar, Non-psychotic Major Depression","enrollment":42},{"nctId":"NCT00519012","phase":"PHASE4","title":"Benefits of Switching Antidepressants Following Early Nonresponse","status":"UNKNOWN","sponsor":"Oizumi Hospital","startDate":"2007-08","conditions":"Depression","enrollment":200}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":14,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["fluoxetine, paroxetine, sertraline","milnacipran, venlafaxine, nortriptyline, mirtazapine"],"phase":"phase_1","status":"active","brandName":"antidepressant non-response","genericName":"antidepressant non-response","companyName":"Samsung Medical Center","companyId":"samsung-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":2,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}